Landmark Alzheimer's Study Retracted After Evidence of Data Manipulation
For years, billions of dollars in research funding and drug development have focused on amyloid plaques as the primary cause of Alzheimer's disease. Drug companies designed treatments to target these plaques, yet clinical trials failed to produce meaningful results — and a recent discovery may explain why. A landmark Alzheimer's study that shaped nearly two decades of research has been retracted due to manipulated images, calling into question the foundation of one of the most dominant theories in Alzheimer's research. The study introduced a specific form of amyloid beta protein as a major driver of memory loss. However, the images that "proved" this protein's existence were altered — and now, the entire claim is unraveling. If the amyloid beta never existed — or was never the Alzheimer's trigger researchers thought it was — then millions of research dollars have been misspent and patients have been led down the wrong path, wasting valuable time and money ...